comparemela.com

Latest Breaking News On - இவன் ரொமெரோ - Page 7 : comparemela.com

Honduras inicia socialización del Plan Nacional de Reconstrucción en Europa

Honduras inicia socialización del Plan Nacional de Reconstrucción en Europa
proceso.hn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proceso.hn Daily Mail and Mail on Sunday newspapers.

Inauguran en Reino Unido sistema de captación de datos para emitir pasaportes hondureños

Inauguran en Reino Unido sistema de captación de datos para emitir pasaportes hondureños
proceso.hn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proceso.hn Daily Mail and Mail on Sunday newspapers.

New clinical trial to test possible therapeutics for COVID-19 in hospitalized patients

The Clinical Trials Network of Tennessee (CTN2) at the University of Tennessee Health Science Center has contracted a new clinical trial to test possible therapeutics for COVID-19 in hospitalized patients. This new trial brings the total generated by CTN2 contracts for the university to nearly $7 million.

Clinical Trials Network brings nearly $7 million in contracts to UTHSC

 E-Mail Memphis, Tenn. (May 11, 2021) - The Clinical Trials Network of Tennessee (CTN2) at the University of Tennessee Health Science Center has contracted a new clinical trial to test possible therapeutics for COVID-19 in hospitalized patients. This new trial brings the total generated by CTN2 contracts for the university to nearly $7 million. Since its launch in 2018, CTN2 has brought more than 200 clinical trial opportunities to the university and the citizens of Tennessee. Steven R. Goodman, PhD, vice chancellor for Research at UTHSC, who led the creation of CTN2, lauded the tremendous success of the nonprofit that enables clinical research faculty across all the UTHSC campuses, who are affiliated with hospitals, to effectively respond to opportunities for clinical trials with pharmaceutical, biotech, and medical device industry partners.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.